Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Oct 1, 2025

Accession no.
0001673232-25-000005
Filed
Oct 1, 2025
Trade date
Sep 29, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 28 non-derivative transactions and 2 derivative transactions. Open-market sales total $9.49M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 29, 2025Common StockMOption exerciseAcquired+14,625$135.42+$1,980,517.514,625Indirect
Sep 29, 2025Common StockSSaleDisposed−650$416.60−$270,79013,975Indirect
Sep 29, 2025Common StockSSaleDisposed−1,235$417.52−$515,637.212,740Indirect
Sep 29, 2025Common StockSSaleDisposed−690$418.80−$288,97212,050Indirect
Sep 29, 2025Common StockSSaleDisposed−1,327$419.77−$557,034.7910,723Indirect
Sep 29, 2025Common StockSSaleDisposed−1,971$420.94−$829,672.748,752Indirect
Sep 29, 2025Common StockSSaleDisposed−2,659$421.75−$1,121,433.256,093Indirect
Sep 29, 2025Common StockSSaleDisposed−2,073$422.72−$876,298.564,020Indirect
Sep 29, 2025Common StockSSaleDisposed−2,206$423.93−$935,189.581,814Indirect
Sep 29, 2025Common StockSSaleDisposed−674$424.80−$286,315.21,140Indirect
Sep 29, 2025Common StockSSaleDisposed−490$425.84−$208,661.6650Indirect
Sep 29, 2025Common StockSSaleDisposed−489$428.64−$209,604.96161Indirect
Sep 29, 2025Common StockSSaleDisposed−96$429.50−$41,23265Indirect
Sep 29, 2025Common StockSSaleDisposed−65$430.75−$27,998.750Indirect
Sep 29, 2025Common StockMOption exerciseAcquired+7,875$146.03+$1,149,986.257,875Indirect
Sep 29, 2025Common StockSSaleDisposed−350$416.60−$145,8107,525Indirect
Sep 29, 2025Common StockSSaleDisposed−665$417.52−$277,650.86,860Indirect
Sep 29, 2025Common StockSSaleDisposed−371$418.80−$155,374.86,489Indirect
Sep 29, 2025Common StockSSaleDisposed−715$419.77−$300,135.555,774Indirect
Sep 29, 2025Common StockSSaleDisposed−1,062$420.94−$447,038.284,712Indirect
Sep 29, 2025Common StockSSaleDisposed−1,432$421.75−$603,9463,280Indirect
Sep 29, 2025Common StockSSaleDisposed−1,116$422.72−$471,755.522,164Indirect
Sep 29, 2025Common StockSSaleDisposed−1,187$423.93−$503,204.91977Indirect
Sep 29, 2025Common StockSSaleDisposed−363$424.80−$154,202.4614Indirect
Sep 29, 2025Common StockSSaleDisposed−264$425.84−$112,421.76360Indirect
Sep 29, 2025Common StockSSaleDisposed−264$428.64−$113,160.9696Indirect
Sep 29, 2025Common StockSSaleDisposed−51$429.50−$21,904.535Indirect
Sep 29, 2025Common StockSSaleDisposed−35$430.75−$15,076.250Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 29, 2025Common StockMOption exerciseDisposed−14,625$0.00$0114,375Indirect
Sep 29, 2025Common StockMOption exerciseDisposed−7,875$0.00$025,375Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)